Laboratorios Farmaceuticos Rovi, S.A. Share Price Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Wiener Boerse
10/09/2026
|
5-day change | 1st Jan Change | ||
| 57.40 EUR | -0.43% |
|
-2.79% | -9.32% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 293.31Cr 340.42Cr 277.72Cr 251.73Cr 472.25Cr 33TCr 474.65Cr 3.3TCr 1.27TCr 17TCr 1.28TCr 1.25TCr 52TCr | P/E 2026 * |
20.5x | P/E 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 291.68Cr 338.54Cr 276.19Cr 250.33Cr 469.64Cr 32TCr 472.02Cr 3.28TCr 1.26TCr 16TCr 1.27TCr 1.24TCr 52TCr | EV / Sales 2026 * |
3.78x | EV / Sales 2027 * | 3.2x |
| Free-Float |
31.63% | Yield 2026 * |
1.71% | Yield 2027 * | 2.04% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
OTC Markets
| LABFF | Delayed | |
|
Tradegate
| 41L | Real-time | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Berne S.E.
| 41L | End-of-day quote | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript : Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -0.43% | ||
| 1 week | -2.79% | ||
| Current month | -5.44% | ||
| 1 month | -0.43% | ||
| 3 months | -1.96% | ||
| 6 months | -28.21% | ||
| Current year | -9.32% |
| 1 week | 57.3 |  | 59.3 |
| 1 month | 57.3 | | 61.8 |
| Current year | 53.15 | | 86.6 |
| 1 year | 53.15 | | 86.6 |
| 3 years | 45.82 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | -2.79% | - | - | 340.42Cr | |
| -0.65% | -2.93% | +47.70% | +86.17% | 99TCr | |
| -0.29% | -3.51% | +49.15% | +62.35% | 64TCr | |
| +0.83% | +0.26% | +17.76% | +72.25% | 45TCr | |
| -0.38% | -3.59% | +30.13% | +35.17% | 34TCr | |
| -0.09% | -13.54% | +13.34% | +24.95% | 26TCr | |
| -0.43% | -2.48% | -0.73% | +9.58% | 25TCr | |
| -1.34% | -13.70% | +36.53% | +44.96% | 20TCr | |
| -3.44% | -7.51% | -20.63% | -59.44% | 19TCr | |
| -0.75% | -4.82% | +25.46% | +87.14% | 18TCr | |
| Average | -0.70% | -5.76% | +22.08% | +40.35% | 38.94TCr | |
| Weighted average by Cap. | -0.51% | -4.42% | +30.96% | +54.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 90Cr 73Cr 66Cr 124.25Cr 8.56TCr 124.88Cr 867.82Cr 333.72Cr 4.35TCr 336.37Cr 328.99Cr 14TCr | 89Cr 103.39Cr 84Cr 76Cr 143.43Cr 9.88TCr 144.15Cr 1TCr 385.22Cr 5.03TCr 388.28Cr 379.77Cr 16TCr |
| Net income | 13Cr 15Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 144.55Cr 56Cr 725.11Cr 56Cr 55Cr 2.29TCr | 17Cr 20Cr 16Cr 15Cr 28Cr 1.93TCr 28Cr 195.55Cr 75Cr 980.92Cr 76Cr 74Cr 3.1TCr |
| Net Debt | -1.62Cr -1.88Cr -1.54Cr -1.39Cr -2.61Cr -179.78Cr -2.62Cr -18Cr -7.01Cr -91Cr -7.07Cr -6.91Cr -289.01Cr | -8.15Cr -9.46Cr -7.72Cr -7Cr -13Cr -903.76Cr -13Cr -92Cr -35Cr -459.8Cr -36Cr -35Cr -1.45TCr |
| Date | Price | Change |
|---|---|---|
| 11/26/11 | €57.70 | +0.52% |
| 10/26/10 | €57.40 | -0.43% |
| 09/26/09 | €57.65 | -1.54% |
| 08/26/08 | €58.55 | -0.68% |
| 07/26/07 | €58.95 | -0.17% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
